Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study

Fig. 3

Proportion of eligible outpatients prescribed statins according to the NCEP ATP III guidelines. * NCEP ATP III indication: a, 0–1 risk factor plus LDL-C ≥ 190 mg/dL; b, ≥2 risk factors plus LDL-C ≥ 130 mg/dL; c, coronary artery disease, transient ischemic attack, stroke, peripheral arterial disease, diabetes mellitus, and LDL-C ≥ 100 mg/dL. Risk factors are listed in full in the Methods section. d † Country income levels: HI, high income; LI/LMI, lower/lower-middle income; UMI, upper-middle income. NCEP ATP III National Cholesterol Education Program Adult Treatment Panel III, LDL-C low-density lipoprotein cholesterol

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us